Overall, the 365 participants in the six studies showed a small response to the SSRIs, but that association disappeared when the researchers accounted for the studies that were completed but never published. When only positive findings get published, and negative ones never see the light of day, the evidence on a topic is said to be subject to "publication bias." As a result of including the unpublished data, "The research made it clear that the effects of (serotonin receptor inhibitors) treatment of (autism spectrum disorders) are considerably overrated," Carrasco and colleagues wrote in the journal Pediatrics.
Dopamine is the neurotransmitter responsible for involuntary movement. And compulsive behavior.
Not Serotonin. There is no reason to even suspect SSRI's will ameliorate these symptoms.
